EN DE
STOCK COMPARISON

Merck KGaA vs Pyridam Farma Tbk: Fair Value & Quality

Both stocks run through our valuation models. Here is how Merck KGaA (MRK) and Pyridam Farma Tbk (PYFA) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Merck KGaA trades at €134 versus a fair value of €109 (-19%), while Pyridam Farma Tbk trades at IDR 222 versus IDR 39 (-82%).
Merck KGaA
MRK.XETRA · EUR · Health Care
-19%
upside to fair value
overvalued
Price€134
Fair Value€109
Quality62/100
Pyridam Farma Tbk
PYFA.JK · IDR · Health Care
-82%
upside to fair value
overvalued
PriceIDR 222
Fair ValueIDR 39
Quality16/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Merck KGaAPyridam Farma Tbk
Valuation
24.1×P/E (TTM)n/a
3.14×P/S (TTM)n/a
2.30×P/Bn/a
12.9×EV/EBITDAn/a
2.76×PEGn/a
−18.9%Fair value upside−82.5%
1.7%Dividend yieldn/a
€2.20Dividend per sharen/a
Profitability
18%Operating margin-0%
1.07×EBIT margin trend (5Y)n/a
9%Return on equity-39%
5%Return on assets-2%
Growth
-3%Revenue growth (YoY)12%
-1.7%Avg. growth/yr (3Y)56.8%
3.8%Avg. growth/yr (5Y)58.3%
+7.3%Value creation/yrn/a
Balance & size
15.5×Interest coverage (EBIT/interest)n/a
0.36×Debt / equity4.25×
$66BMarket cap$263M
mixedGrowth qualityexpensive

Merck KGaA leads: 5 to 2 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Merck KGaAof which business quality 61 · market factors 66 Pyridam Farma Tbkof which business quality 16 · market factors 24
ProfitabilityMargins and returns on capital today
41
7
Quality GrowthAre margins and returns improving?
40
68
CashflowEarnings quality: real cash, not paper profit
57
10
Fin. StrengthBalance sheet, leverage, solvency risk
76
2
InvestmentDisciplined investing over empire-building
80
28
Low VolatilityCalm price path (market factor)
72
42
MomentumPrice trend over the last 3–12 months (market factor)
61
23
52W MomentumDistance to the 52-week high (market factor)
68
5
Net IssuanceShare count: buybacks or dilution?
82
0

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyMerck KGaAPrice €134Pyridam Farma TbkPrice IDR 222
DCF Models-20%below the price€107n/a
Earnings-Based-60%below the price€53.25n/a
Dividend Discount-70%below the price€40.71n/a
Multiples-12%close to the price€118n/a
Asset-Based-67%below the price€44.06-79%below the priceIDR 46
Growth DCF-29%below the price€94.57n/a
Economic Profit-50%below the price€66.44n/a
Growth Earnings-14%close to the price€115n/a
Minimum-70%below the price€40.71-79%below the priceIDR 46
Maximum-12%close to the price€118-79%below the priceIDR 46
Median-40%below the price€80.50-79%below the priceIDR 46
Geometric mean-45%below the price€73.75-79%below the priceIDR 46

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Merck KGaA: 23 of 26 models see the stock below the current price.

Pyridam Farma Tbk: 1 of 1 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Merck KGaA
Price €134
Fair Value €109
Bear €59.91Bull €150
Pyridam Farma Tbk
Price IDR 222
Fair Value IDR 39
Bear IDR 29Bull IDR 58

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Merck KGaA · Health Care

Quality score62 · above median
Fair value upside-19% · above median

Pyridam Farma Tbk · Health Care

Quality score16 · bottom 25%
Fair value upside-82% · bottom 25%

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Merck KGaA trades at €134 versus a fair value of €109 (-19%), while Pyridam Farma Tbk trades at IDR 222 versus IDR 39 (-82%).

Merck KGaA has the higher quality score (62/100).

Open Merck KGaA live analysis →
Merck KGaA · Pyridam Farma Tbk

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Merck KGaA

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Pyridam Farma Tbk

Alphabet Inc Class C vs Meta PlatformsCisco Systems vs NvidiaMicrosoft vs Taiwan Semiconductor ManufacturingApple vs Cisco Systems
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.